Bringing High-Impact Medical Innovations to Life Through Risk-Reward Sharing Partnerships

Learn More

Orchestra BioMed is a Biomedical Innovation Company

Orchestra BioMed is a biomedical innovation company focused on developing high-impact therapeutic products to address significant unmet needs in procedure-based medicine.

Our partnership-enabled business model is designed to advance promising therapeutic solutions through development and aims to leverage strategic partnerships with established global strategics to optimize commercialization and profitability. Orchestra BioMed is led by an accomplished team of leaders with strong expertise in every phase of medtech and biopharma product development. Our primary goal is to rapidly advance transformative solutions that may have the potential to improve care for millions of patients worldwide.

Product Pipeline Overview

Advancing a multi-asset pipeline of high-impact therapeutic solutions.

Learn More

News & Events

How Can Early-Stage Medical Device Companies Survive Market Turmoil?

May 23, 2020

Medical Device and Diagnostic Industry (MD+DI)

David Hochman, founder and CEO of Orchestra BioMed, shares how the company's risk-reward sharing business model has helped it stay afloat during the coronavirus pandemic.

Click here for full article

Daniel Burkhoff, MD, PhD, presented data from our MODERATO II double-blind, randomized study of BackBeat Cardiac Neuromodulation Therapy ™ at the 2020 Heart Rhythm Scientific Sessions online

May 8, 2020

Event: 2020 Heart Rhythm Scientific Sessions online
Webcast: https://cslide-us.ctimeetingtech.com/hrs20/attendee/eposter/poster/1407?q=burkhoff

Read All News